Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What a shamless way of making money!!!!!
Nicely put Frenchy. All good for 2019 to us all.
That is what I am wondering too.....
Hit the nail on the head....
High expectations filing MRTP today by the market failing to execute reflects on the pps ....
!!!!!!!!!!!!!!!!!!!!!
I agree...
Motley Fool come up with below article claiming FDA will restrict nicotine levels but big T will fight against it and will delay years. What a mickey mouse . Motley wrote a article way back claiming FDA will not limit nicotine but now they take a notch down claiming FDA will limit but it will take years to implement. So obvious they are trying to weather the coming the mother of storm ,XXII.
Why 22nd Century Group Stock Bolted Higher in November
Motley Fool
George Budwell, The Motley Fool
,Motley Fool•December 11, 2018
What happened
Shares of the plant biotech company 22nd Century Group (NYSEMKT: XXII) broke out of their year-long funk last month by gaining a whopping 22%, according to data from S&P Global Market Intelligence. What event sparked this double-digit rally?
22nd Century Group's shares took flight after the company posted its third-quarter earnings report on Nov. 7. The key item that seems to have encouraged investors was the news that the company was inching ever closer to finally submitting a Modified Risk Tobacco Product application for its proposed "very low nicotine content premium cigarettes," or VLNC premium cigarettes for short.
A person's hand holding a lit cigarette.
A person's hand holding a lit cigarette.
More
Image Source: Getty Images.
So what
22nd Century Group's VLN premium cigarettes are designed to lower the potential for abuse and addiction stemming from regular tobacco use. The basic idea is to piggyback on the Food and Drug Administration's (FDA) tobacco harm-reduction initiative. Under a best case scenario, this antismoking initiative would entice tobacco companies operating stateside to license 22nd Century Group's VLN products outright or pay a hefty fee to use its intellectual property.
Now what
Is the FDA's ongoing effort to basically eradicate combustible cigarettes a worthwhile investing thesis? Frankly, the answer is probably no. Big tobacco may not be able to win this fight with regulators at the end of the day, but this powerful industry can certainly delay it -- perhaps for decades. That fact doesn't bode well for a cash-flow-negative company like 22nd Century Group.
Moreover, it's not altogether clear if there would even be much demand for a low-nicotine cigarette. Most smokers, after all, consume cigarettes primarily for a nicotine fix. 22nd Century Group's VLN premium cigarettes, therefore, appear to have a rather limited commercial opportunity from the outset.
More From The Motley Fool
10 Best Stocks to Buy Today
3 Stocks That Are Absurdly Cheap Right Now
5 Warren Buffett Principles to Remember in a Volatile Stock Market
The $16,728 Social Security Bonus You Cannot Afford to Miss
Well being: Smoking Low-Nicotine Cigarettes Reduces The Quantity Of Chemical compounds People who smoke Inhale: Thank You For Smoking… Much less?
by Denis Bedoya | Dec 9, 2018 | Health
When low-nicotine cigarettes were introduced as a way for smokers to lessen their habit, and possibly quit altogether, some experts believed it would lead them to overcompensate. Yet, that’s not what new research published in the journal Cancer Epidemiology, Biomarkers & Prevention found.
It was a small, month-long study that followed 72 smokers, ages 18 to 65, who smoked regular cigarettes for one week before switching over to low-nicotine cigarettes for the remaining three weeks. Instead of smokers, well, smoking more low-nicotine cigarettes to make up for the nicotine they’d get from a regular cigarette (12 milligrams), the researchers found no change in their smoking habits.
“Smokers are unable or unwilling to compensate when there is markedly less nicotine in the cigarette and when the experience of smoking is far less rewarding,” said David Hammond, lead study author and an associate professor in the School of Public Health and Health Systems at the University of Waterloo in Ontario, Canada, in a press release. “Our study may help regulators anticipate the possible consequences of mandatory nicotine reductions in cigarettes.”
The nicotine levels in the alternative cigarettes were 8.9 mg, 8.4 mg and 0.6 mg, respectively. And Hammond found that when study participants submitted urine and breath samples at the end of each week, they were consuming the same amount of cigarettes despite lesser levels. Better yet, there was also no difference in the levels of carbon monoxide.
This would mean low-nicotine cigarettes are both a viable option for those looking to adjust their smoking habit, as well as a way to minimize exposure to those cancer-causing chemicals. This may be what the Food and Drug Administration needs to hear in order to finally regulate nicotine levels.
“There is ample evidence from inside and outside the tobacco industry that major reductions in the nicotine content of cigarettes would result in a less-addictive product,” Hammond said. “Overall, the impact of a less-addictive cigarette on reducing smoking uptake and cancer prevention is potentially massive.”
According to the Centers for Disease Control and Prevention, 42.1 million people in the United States smoke cigarettes. It’s the leading cause of preventable death, with tobacco smoke containing a deadly mix of over 7,000 chemicals. For the 68 percent of smokers that report wanting to quit completely, low-nicotine cigarettes may be the place to start.
Source: Hammond D, O’Connor R. Reduced Nicotine Cigarettes: Smoking Behavior and Biomarkers of Exposure among Smokers Not Intending to Quit. Cancer Epidemiology, Biomarkers & Prevention. 2014.
Post Views: 143
Submit a Comment
Your email address will not be published. Required fields are marked *
interesting read posted on Yahoo board.
No mentioning of XXII?????
Diddo Zedster. Thank you for detailed time line.
My point is back in 60ties cigarette companies swear in front of million people that nicotine is not addictive. There is a movie about it also, whistler was the name ifI am correct. Since then and now it is proven several times, stamped and sealed that nicotine is addictive. Hence what the bigT is fighting about. They were liars from the get go and killed millions why FDA should listen to them now.
FDA acceptance is within 30 days isn't it? That is the word going around am I mistaken?
This might explain big dealings yesterday after the market closed.
Cat is out of the bag.
You think XXII will be one of the major player?
Slim trading today. Seems shorts taking no action not to be caught on the wrong foot. Longs waiting for the next shoe to drop to enjoy mulla....
At this down ( more to come) market days, I would assume everyone would look for safe harbours. XXII should be safe to brush these days considering the upside news to come...
Here we go let the yoyo game start..... Ready to rumble....
Some idiot came in this morning and paid $2.69 for 10,000 and change shares then a smart guy bought 200 shares at $2.62 and pps dropped. Who is this 10,000 and change idiot owner of XXII? And who is the smart guy ?
It seema XXII is following tobacco stocks today but XXII is not tobacco stock!!!!
Now is the time to ask that question to Henry. Call up and ask the question...
Great suggestion. Gio should join the CC and ask and make his comments to Henry...
Day after day year over year same play that bugs my mind. Like to day someone pays $2.28 for 8thousand and change. Then someone drops the price down to $2.24 with 100 shares trade. Big share buyers are schmucks? Can someone explain this to me???
Today supposed to be a great day for XXII where nicoting reduction is discussed in depth at FDA meeting , not?????
Very good point....
You think the sudden drop with pps price is due to no mentioning of nicotine reduction at the meeting???
It seems that XXII long time investors either the smartest or the dumpest investors so far. It has been more the five years non other then us still hanging on with XXII hoping that it will rise to the expectation. So market still not seeing the future with XXII or XXII is a bust???
It seems that XXII long time investors either the smartest or the dumpest investors so far. It has been more the five years non other then us still hanging on with XXII hoping that it will rise to the expectation. So market still not seeing the future with XXII or XXII is a bust???
In nut shell that is what I am wondering too....
2020 time frame may give a hand to shorts to take down the pps. further down...
Can you say it is typical XXII. Very positive news, positive coverage but pps. is down.....
Thank you for an update. What do you mean by No VLN available????
Perfect esad. Is the presentation will reflect on XXII pps? Still red though....
There was supposed to be a FDA conference about lowering nicotine levels..... The conference is cancelled???? XXII is going down again..
What is "hoarses"????
yo yo game started again.....
yeeyyyy......
I have been with XXII since 2012. Now I am convinced till XXII start generating consistent revenue stream ( not 3 million here 5 million there spectrum sales) pps will hover around $2 and $3. Until then it is a waiting game..
Hope you are correct. After issuence of long waited very positive(supposedly) report one expect different response, don't you. XXII existence very much depends on this report but ........